She received her PhD in Biostatistics from MUSC (2014). As a recent graduate, her dissertation work focused on the design of adaptive trials for seamless Phase II-III dose selection designs. Current research interests include methodological development to address the challenges of adaptive designs and randomization in the context of rapid treatment trials and rare diseases.